It's time for precisionmedicine in acute care

See peopledifferently

Healthcare should be tailoredto your biology

It's time for precision medicine in acute care

See people differently

Healthcare should be tailored to your biology

A Personalized Medicine Revolution

Prenosis leverages its ImmunixTM precision medicine platform to develop new precision medicine tools and to implement them in real time into workflow.

Learn More

FDA De NovoAuthorized

The Sepsis ImmunoScoreTM is the first-ever FDA authorized AI Diagnostic for Sepsis for the diagnosis of sepsis and the prediction of adverse outcomes.

News

Electronic Medical Records Integration

The ImmunoScoreTM is available to integrate directly into hospital Electronic Medical Records. It’s also available via an exclusive partnership with Roche Diagnostics.

Learn More

BIOLOGICAL INSIGHTS TO DELIVER THE RIGHT PRECISION THERAPY.

Fast-moving acute care conditions pose a significant challenge for healthcare providers.

In modern hospital settings, providers still rely on symptom-based diagnoses rather than a patients’ unique biology. At Prenosis, our mission is to empower clinicians to see people differently by equipping them with a deep understanding of each patient’s biology. Using this understanding, clinicians can tailor treatments to individual needs and improve outcomes.

In modern hospital settings, providers still rely on symptom-based diagnoses rather than a patients’ unique biology. At Prenosis, our mission is to empower clinicians to see people differently by equipping them with a deep understanding of each patient’s biology. Using this understanding, clinicians can tailor treatments to individual needs and improve outcomes.

Nurse with man in wheelchair

A cutting-edge artificial intelligence powered diagnostic, the Sepsis ImmunoScoreTM is the first FDA authorized AI diagnostic for sepsis. By seamlessly integrating biomarkers and clinical data, our diagnostic presents real-time critical information, predicts future outcomes for patients, and expedites the delivery of optimal therapy. With direct integration into hospital Electronic Health Records, the Sepsis ImmunoScoreTM enables timely interventions that improve patient outcomes, improve hospital quality metrics, and drive down hospital costs.

The World's Largest Biobank Linked to Clinical Data for Infection in Acute Care, built by the ImmunixTM precision medicine platform.

ImmunixTM simultaneously enables the development and validation of new precision medicine tools and the real-time implementation of those tools to improve patient care and outcomes.

10

hospitals and growing

100,000+

Longitudinal Specimens

25K+

Patients – Broad, Longitudinal Clinical Data

Solutions

Immunix™

Our ImmunixTM precision medicine platform, which has produced the world’s largest and fastest growing biomarker-clinical dataset for infection in acute care, leverages machine learning algorithms to illuminate the complex biological states of patients more comprehensively.

Learn more

ImmunoScore™

Using ImmunixTM, we created and validated the Sepsis ImmunoScoreTM, the first FDA authorized AI diagnostic for sepsis detection. Leveraging biomarkers, clinical data and AI, the Sepsis ImmunoScoreTM holistically evaluates a patient’s chances of experiencing adverse outcomes within 24 hours.

Learn more

ImmunoScoreTM

Already Part of your Workflow

Easily integrates into your current clinical workflow and relies on data you already collect. No additional equipment needed.

Collect

Providers collect routine medical history, vitals, demographic data, traditional lab results and new biomarker measurements on patients suspected of having a serious infection that could lead to a deadly immune response.

Analyze

Using 22 parameters, the Sepsis ImmunoScoreTM uses machine learning to rapidly identify and categorize the individual’s biological response to evaluate the risk of the patient having or developing sepsis within the next 24 hours.

Inform

With a direct integration into hospital EMRs, the ImmunixTM platform displays the results of the Sepsis ImmunoScoreTM, including full transparency into how the score was calculated for each individual patient.

Potential Benefits for U.S. Hospitals

Reduce
Mortality

Decrease Hospital
Costs

Reduce Hospital
Length of Stay

Evidence

In The News

Latest Insights

Hello world!

Read More

Passionate. Experienced. Practical.

At Prenosis, we are driven to decode the atypical human immune response with simple, easy-to-use tools that help physicians improve patient care and outcomes. Our team has both the expertise and experience to deliver on that promise.

Management Team

Bobby Reddy, Jr., Ph.D.

Co-Founder / CEO / Board Member

Read More plus symbol

Angela McFarland

Chief Financial Officer

Read More plus symbol

Carlos Lopez-Espina

SVP of Research & Development

Read More plus symbol

Robin Carver, RN, MSN, CIC

VP of Health System Management

Read More plus symbol

Brian Bray

VP of Technology

Read More plus symbol

Jay Kaminski

Head of Pharma Strategy

Read More plus symbol

Nathan I. Shapiro, MD, MPH

Head Advisor for Clinical Research

Read More plus symbol

Board of Directors

Gary Kurtzman, MD

Read More plus symbol

Sean Murphy

Read More plus symbol

Edward Ogunro, Ph.D.

Read More plus symbol

Julia Monfrini Peev

Read More plus symbol

Bobby Reddy, Jr., Ph.D.

Read More plus symbol

Jim Zhao

Read More plus symbol

Maria Siambekos
(Board Observer)

Read More plus symbol

Clinical & Scientific Advisory Board

Kevin Klauer, DO, EJD, FACEP, FACOEP

Read More plus symbol

Pratik Sinha, MD, PhD

Read More plus symbol

Philip A. Verhoef, MD, Ph.D.

Read More plus symbol

David Sihai Zhao, Ph.D.

Read More plus symbol

Ruoqing Zhu Ph.D

Read More plus symbol

Other Advisors

Rashid Bashir Ph.D

Read More plus symbol

Suzy Lebold Ph.D.

Read More plus symbol

Nam Nguyen

Read More plus symbol

Mark Wagner

Read More plus symbol

Get in Touch

Have questions? Let’s connect.

Chicago Office

3440 S Dearborn Street, Suite 222S
Chicago, IL 60616


E info@prenosis.com
P 312-235-3580


    I consent to receive communications via email from Prenosis